Physician profile

David Tran

Internal Medicine · Covington, LA

NPI 1366419590

$31,657.40

in general payments reported to CMS, 2019-2025

73 companies · $4,243 in 2025

The $4,243 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$15,118.31
Education$12.01

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals Lp $5,795.25 2019-2025 Breztri, Farxiga, Airsupra
Abbvie INC. $3,182.32 2021-2025 Vraylar, Ubrelvy, Qulipta
Novo Nordisk INC $2,902.94 2019-2025 Ozempic, Rybelsus, Wegovy
Lilly USA, LLC $2,115.79 2019-2025 Mounjaro, Jardiance, Zepbound
Pfizer INC. $1,410.26 2019-2025
Allergan, INC. $1,222.26 2019-2021
Amgen INC. $1,171.71 2021-2025 Repatha, Otezla, Otezla
Boehringer Ingelheim Pharmaceuticals, INC. $1,129.68 2019-2025 Jardiance, Tradjenta, Synjardy
Axsome Therapeutics, INC. $1,036.72 2022-2025 Auvelity, Sunosi, Symbravo
Bayer Healthcare Pharmaceuticals INC. $927.75 2022-2025
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $875.68 2019-2025 Xifaxan, Relistor, Trulance
Kowa Pharmaceuticals America, INC. $857.07 2019-2023 Seglentis, Livalo
Lundbeck LLC $724.83 2022-2025 Rexulti
Supernus Pharmaceuticals, INC. $684.38 2022-2025 Qelbree, Qelbree, Xyosted
Glaxosmithkline, LLC. $523.55 2022-2025 Trelegy Ellipta
Show all 73 companies
CompanyGeneral paymentsYearsTop products
Astellas Pharma US INC $520.21 2019-2022
Merck Sharp & Dohme LLC $514.91 2019-2025 Keytruda, Belsomra, Verquvo
Sanofi-Aventis U.S. LLC $458.09 2019-2022
Otsuka America Pharmaceutical, INC. $365.99 2019-2025 Rexulti, Nuedexta
Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) $353.78 2022-2025 Caplyta
Biohaven Pharmaceuticals, INC. $353.17 2021
Horizon Therapeutics Plc $307.69 2019-2023 Krystexxa
Ironwood Pharmaceuticals, INC $301.14 2019-2023 Linzess
Idorsia Pharmaceuticals US INC $300.14 2022-2024 Quviviq
Esperion Therapeutics, INC. $298.89 2020-2023 Nexletol
Takeda Pharmaceuticals U.S.A., INC. $270.14 2019-2023 Trintellix
Antares Pharma, INC. $225.76 2024-2025 Xyosted
Harmony Biosciences LLC $217.11 2023-2025 Wakix
Sunovion Pharmaceuticals INC. $193.21 2019-2020
Amarin Pharma, INC. $192.40 2019-2020
Janssen Pharmaceuticals, INC $155.70 2019-2021
Kyowa Kirin, INC. $149.86 2020-2022
Noven Therapeutics, LLC $140.47 2025 Xelstrym
Upsher-Smith Laboratories LLC $130.47 2020-2022
Tolmar, INC. $116.36 2024-2025 Jatenzo
Nevro Corp. $113.49 2019-2022
Novartis Pharmaceuticals Corporation $100.96 2021-2022
Eisai INC. $95.15 2020-2025
Biogen, INC. $89.72 2020-2022
Janssen Biotech, INC. $83.33 2021
Vertiflex, INC. $78.12 2019
Nestle Healthcare Nutrition INC. $71.54 2022-2023
Stryker Corporation $68.57 2023-2025 Variax, Clottriever Bold Catheter, Fixos
Abbott Laboratories $53.64 2022-2025 Freestyle Libre 3
Corium, LLC $47.87 2023 Azstarys
Vertex Pharmaceuticals Incorporated $43.02 2025
E.R. Squibb & Sons, L.L.C. $41.88 2020-2024 Eliquis
Assertio Therapeutics, INC. $37.52 2019
Clarus Therapeutics INC. $36.06 2021
Inspire Medical Systems, INC. $35.85 2025 Inspire
Tactile Systems Technology INC $35.61 2021-2024 Entre Plus, Flexitouch Plus
Acerus Pharmaceuticals Corporation $34.06 2022
Halozyme INC $32.80 2023
Biohaven Pharmaceutical Holding Company Ltd. $32.59 2022
Currax Pharmaceuticals LLC $31.86 2021-2024 Onzetra Xsail, Contrave
Tris Pharma INC $29.36 2022
Jazz Pharmaceuticals INC. $28.89 2020-2021
Bioxcel Therapeutics, INC. $28.46 2023 Igalmi
Intra-Sana Laboratories $26.01 2025 Glycate, Reltone 200 Mg, Reltone 400 Mg
Boston Scientific Corporation $24.42 2025 Watchman Flx
Alexion Pharmaceuticals, INC. $24.19 2023
Dexcom, INC. $23.80 2024 Dexcom G6 Transmitter
Kerecis Limited $23.14 2025 Kerecis Surgiclose, Kerecis Graftguide
Shield Therapeutics INC $19.50 2023 Accrufer
Avanir Pharmaceuticals, INC. $19.48 2022
Sumitomo Pharma America, INC. $19.47 2023 Gemtesa
Renalytix Ai, INC. $16.36 2023 Kidneyintelx Blood Collection Convenience Kit
Advanced Respiratory, INC $16.01 2019
Teva Pharmaceuticals USA, INC. $15.86 2022
Exact Sciences Corporation $14.92 2023 Cologuard Collection Kit
Promius Pharma LLC $14.21 2019
Genentech USA, INC. $13.09 2019
Acadia Pharmaceuticals INC $10.91 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

David Tran

$31,657.40

in general payments reported 2019-2025

Years
2019-2025
Top company
Astrazeneca Pharmaceuticals Lp
Context
The $4,243 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).

https://glasscript.com/doctor/16846/david-tran

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.